I am pleased to welcome you to the Department of Pharmacology and Physiology, one of four basic science departments at Drexel University College of Medicine.
Our mission is to provide outstanding education and training to our students that will serve as the foundation for lifelong contributions to the biomedical and health sciences. We emphasize a collaborative atmosphere with the objective of fostering high quality, interdisciplinary research.
The disciplines of pharmacology and physiology touch on virtually every scientific discipline and clinical area within the biomedical sciences, providing students with a range of opportunities to explore disease mechanisms and altered physiological processes, new pharmacological tools and new medications.
We are unique in offering educational programs not only in the basic sciences of pharmacology and physiology but also in drug discovery and development, which provides students with a wealth of advantages in considering career opportunities within academic, biopharmaceutical and pharmaceutical settings.
Our faculty pursue a wide variety of research interests in the areas of neurological and neuroinflammatory disorders, cancer therapeutics, pain, cardiovascular and renal physiology, drug addiction and HIV infection/neuropathology. These efforts are intertwined with a strong education and research program in Drug Discovery and Development, including an active component of Medicinal Chemistry. This translational approach is at the basis of our work, firmly rooted in the concept of promoting a seamless and continuous transition between the basic and the clinical sciences.
We invite you to explore the research interests of our faculty and inquire if you have questions. Additional information about the faculty — such as publications and laboratory information — can be found on their biography pages.
Drug Discovery and Development Program at Drexel University College of Medicine
A new comprehensive program offering a Master of Science in Drug Discovery and Development.
Learn more about the program
Meet a Student
Melissa Manners, who successfully defended her doctoral thesis in March, has been studying the role of the epigenetic regulator methyl-CpG-binding protein 2 (MeCP2) in modulating pain. Mutations in MECP2 cause Rett syndrome, and it has been observed that people with Rett syndrome have reduced pain sensitivity. What Manners did was to show the molecular link between MeCP2 and pain.
News and Announcements
Dr. Meucci Receives NIH R21 Grant
Olimpia Meucci, MD, PhD, received an R21 grant from the NIH National Institute on Drug Abuse for her project "Effects of HIV-1 neurotoxins on lipid rafts-associated proteins."
Drs. Fatatis and Meucci Receive NIH R01 Grant
Alessandro Fatatis, MD, PhD, and Olimpia Meucci, MD, PhD, received an R01 grant from the National Cancer Institute of the NIH for a project titled "Role of CX3CR1 in breast cancer metastasis."
See all news
Upcoming & Recent Events
Robert Ring, PhD: The Autisms: A Proving Ground for Drug Discovery in Spectrum Disorders
See full seminar calendar
Back to Top